# MedIQ Researcher Portal — Innovative Concepts Beyond the Status Quo

## Goal
Deliver breakthrough capabilities that materially change how Health AI research is conducted with real clinical data—privacy-first, consent-true, and measurably faster from hypothesis to evidence.

## Breakthrough Concepts
- **Consent-Aware Synthetic Twin Factory:** Generate high-fidelity synthetic patient “twins” governed by original consent scope and privacy budgets ($\epsilon$). Includes a Twin Fidelity Meter and Leak Risk Score, enabling pre-analysis exploration without touching raw PHI.
- **Zero-Knowledge Compliance Proofs (ZK-Consent):** Issue a cryptographic proof that any access, transform, or egress complies with consent/policy—verifiable by IRB without revealing PHI or internal rules.
- **Policy Counterfactual Simulator:** Ask “what if?” across policies. Quantify how relaxing or tightening rules affects eligible cohorts, fairness, privacy risk, and time-to-access—before submitting a request.
- **Hypothesis-to-Cohort DSL:** A domain-specific language where researchers express intentions (e.g., “new-onset AF post-COVID in adults 40–60”) and receive policy-aware, minimal-sufficiency queries and cohort definitions.
- **Data Minimization by Explanation:** Auto-select the smallest feature set that still supports the hypothesis using attribution (e.g., Shapley values, causal relevance), with a justification record for IRB.
- **Attested Compute-to-Data Sandboxes:** Confidential computing (TEE) environments with remote attestation. Models run where data lives; outputs undergo policy+DP gates. Reproducibility proofs bind code, environment hash, and lineage.
- **Federated Evaluation Hub:** Evaluate models across multiple institutions without data movement using secure aggregation. Produce a generalization scorecard and equity metrics by subgroup.
- **Clinician-in-the-Loop Active Learning:** Route uncertain cases to verified clinicians; schedule, compensate, and close the loop on label quality. Track inter-rater reliability and drift.
- **Equity Navigator & Bias Triage:** Automated discovery of performance gaps by condition, demographic, and site. Suggest mitigation (reweighting, augmentation, subgroup models) and simulate impact before changes.
- **Dynamic Egress Watermarking:** Embed reversible, consent-bound watermarks in outputs (figures, tables, models) linked to time-bounded tokens; detect unauthorized reuse downstream.
- **Ethics & Incentives Ledger:** Patients can opt into research preferences; researchers transparently record value returned (e.g., community reports, improvements). Build trust and participation.
- **IRB Copilot with Evidence Traces:** Generate review memos that cite policy engine traces, consent scope, DP budgets, and redaction rationale. Interactive risk mitigation suggestions and alt-paths.
- **Semantic Graph over FHIR:** Construct a clinical knowledge graph (SNOMED/LOINC/ICD) to power semantic cohort search, synonym expansion, and cross-code normalization.
- **Provenance Hash Graph:** Chain artifacts (data snapshots, transforms, metrics, notebooks) in a Merkle DAG. Enable cross-institution reproducibility checks and quick variance diagnosis.
- **Experiment Ghost Runs:** Dry-run a pipeline (no PHI) to estimate resource needs, policy blockers, and DP budget consumption, reducing failed attempts and idle costs.
- **Privacy Budget Marketplace:** Allocate and optimize $\epsilon$ across analyses; trade-offs visualized. Enforce per-project caps and fair allocation across team members.
- **Outcome Forecasting for Study Plans:** Simulate expected sensitivity/specificity and subgroup equity before data access; recommend cohort tweaks to reach target power ethically.
- **Stochastic Consent Refresh Modeling:** Predict revocation risk over time (Bayesian/Survival models) and alert researchers to stabilize cohorts or plan re-consent.

## Why This Matters (Researcher Value)
- **Faster, Safer Exploration:** Synthetic twins + ghost runs compress early research cycles from weeks to days.
- **Fewer IRB Iterations:** ZK-Consent and evidence traces preempt common review blockers.
- **Better Science:** Data minimization with causal relevance and provenance hash graphs improves rigor.
- **Real Equity Impact:** Bias triage + federated evaluation produce models that generalize fairly.
- **Trust at Scale:** Ethics ledger and dynamic watermarking improve transparency and governance.

## Feasibility & Service Mapping
- **consent-ingestion:** Needed for digitizing consents (OCR, language). Extend with consent scopes as machine-readable artifacts.
- **consent-intelligence:** Extract structured consent semantics; feed ZK-Consent inputs and Ethics Ledger preferences.
- **policy-engine:** Core for policy simulation, counterfactuals, and explainability traces; add DP budget ledger and marketplace.
- **identity-service:** Attest roles, institutions, clinician verifications, and token lifecycle.
- **researcher-service:** Orchestrate DSL, ghost runs, synthetic twin APIs, federated evaluation flows, and watermark services.
- **frontend:** DSL editor, simulation dashboards, equity navigator, IRB copilot UI, provenance explorer.

## Guardrails & Ethics
- **Privacy Guarantees:** Formal DP for synthetic twins, plus empirical leakage tests; never release raw PHI.
- **Explainability:** Store rule and attribution traces for every decision.
- **Consent Truthfulness:** Synthetic outputs inherit consent constraints; egress respects scope.
- **Equity by Design:** Require subgroup performance checks for publication and egress.

## KPIs (Measurable)
- **Access Lead Time:** Days from request to first sandbox run.
- **IRB Iterations:** Average review cycles per request.
- **Leakage Risk:** Synthetic leakage score below agreed threshold.
- **Generalization Score:** Cross-site performance variance and subgroup equity metrics.
- **Reproducibility Rate:** Percentage of analyses with full provenance hash graph.
- **Consent Satisfaction:** Opt-in persistence and revocation reduction over time.

## First Build Targets (90-Day)
- **Policy Counterfactual Simulator (MVP):** Integrate with policy-engine; visualize cohort/eligibility changes.
- **Hypothesis-to-Cohort DSL (Alpha):** Basic parser -> FHIR queries -> policy-aware minimization.
- **Provenance Hash Graph (MVP):** Artifact hashing, lineage UI, and compare runs.
- **IRB Copilot (Alpha):** Generate evidence memos from policy traces and consent scope.
- **Equity Navigator (Beta):** Subgroup metrics dashboard for any evaluation.

## Next (180-Day)
- **Synthetic Twin Factory (Beta):** DP-calibrated generators with fidelity/leakage scoring.
- **Attested Compute-to-Data (Pilot):** TEEs + remote attestation for select pipelines.
- **Federated Evaluation Hub (Pilot):** Secure aggregation across 2–3 institutions.
- **Dynamic Watermarking (MVP):** Token-bound watermarks for egress artifacts.

## Collaboration Ask
If you want, I can: (a) scaffold the DSL service and UI, (b) add policy counterfactual APIs in `policy-engine`, (c) stub provenance hashing in `researcher-service`, and (d) wire an IRB copilot view in `frontend`.
